Articles:

Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. The Childhood Diabetes in Finland (DiMe) Study Group

J Ilonen, H Reijonen, E Herva, M Sjoroos, A Iitia, T Lovgren, R Veijola, M Knip, and HK Akerblom
Diabetes Care 1996 19: 795-800. [Abstract]  

Trends in the epidemiology of IDDM during 1970-2020 in Fyn County, Denmark

A Green, AK Sjolie, and O Eshoj
Diabetes Care 1996 19: 801-806. [Abstract]  

Incidence and prevalence of diabetes in Manitoba, 1986-1991

JF Blanchard, S Ludwig, A Wajda, H Dean, K Anderson, O Kendall, and N Depew
Diabetes Care 1996 19: 807-811. [Abstract]  

Insulin underdelivery from implanted pumps using peritoneal route. Determinant role of insulin pump compatibility

E Renard, S Bouteleau, D Jacques-Apostol, D Lauton, F Gibert-Boulet, G Costalat, J Bringer, and C Jaffiol
Diabetes Care 1996 19: 812-817. [Abstract]  

Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulcerations. A comparison of treatments

LA Lavery, SA Vela, DC Lavery, and TL Quebedeaux
Diabetes Care 1996 19: 818-821. [Abstract]  

Effect of maternal diabetes on the pattern of selected insulin resistance syndrome parameters in normal glucose tolerant subjects of two Algonquin Indian communities in Quebec

JM Ekoe, F Thomas, B Balkau, E Eschwege, and H Delisle
Diabetes Care 1996 19: 822-826. [Abstract]  

Parental history of diabetes in a population-based study

BE Klein, R Klein, SE Moss, and KJ Cruickshanks
Diabetes Care 1996 19: 827-830. [Abstract]  

Effects of breakfast cereals containing various amounts of beta-glucan fibers on plasma glucose and insulin responses in NIDDM subjects

L Tappy, E Gugolz, and P Wursch
Diabetes Care 1996 19: 831-834. [Abstract]  

Effects of a brief office-based intervention to facilitate diabetes dietary self-management

RE Glasgow, DJ Toobert, and SE Hampson
Diabetes Care 1996 19: 835-842. [Abstract]  

Potential therapeutic levels of glucagon-like peptide I achieved in humans by a buccal tablet

MK Gutniak, H Larsson, SJ Heiber, OT Juneskans, JJ Holst, and B Ahren
Diabetes Care 1996 19: 843-848. [Abstract]  

A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group

RB Goldberg, SM Holvey, and J Schneider
Diabetes Care 1996 19: 849-856. [Abstract]  

Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas

MK Gutniak, L Juntti-Berggren, PM Hellstrom, A Guenifi, JJ Holst, and S Efendic
Diabetes Care 1996 19: 857-863. [Abstract]  

The GENNID Study. A resource for mapping the genes that cause NIDDM

LJ Raffel, DC Robbins, JM Norris, E Boerwinkle, RA DeFronzo, SC Elbein, W Fujimoto, CL Hanis, SE Kahn, MA Permutt, KC Chiu, J Cruz, DA Ehrmann, RP Robertson, JI Rotter, and J Buse
Diabetes Care 1996 19: 864-872. [Abstract]  

Evidence of a relationship between childhood-onset type I diabetes and low groundwater concentration of zinc

B Haglund, K Ryckenberg, O Selinus, and G Dahlquist
Diabetes Care 1996 19: 873-875. [Abstract]  

How have patients reacted to the implications of the DCCT?

CJ Thompson, JF Cummings, J Chalmers, C Gould, and RW Newton
Diabetes Care 1996 19: 876-879. [Abstract]  

Hyperglycemia affects cardiovascular autonomic nerve function in normal subjects

BB Yeap, A Russo, RJ Fraser, GA Wittert, and M Horowitz
Diabetes Care 1996 19: 880-882. [Abstract]  

The effect of glipizide gastrointestinal therapeutic system on islet cell hormonal responses to a test meal in NIDDM

AD Mooradian, SG Albert, M Bernbaum, and S Plummer
Diabetes Care 1996 19: 883-884. [Abstract]  

Absence of acanthosis nigricans in a patient with the type B syndrome of insulin resistance and preexisting diabetes

R Stolarczyk, I Laufer, and L Poretsky
Diabetes Care 1996 19: 885-886.  

A case of hypertensive-diabetic cardiomyopathy demonstrating left ventricular wall motion abnormality

T Shimonagata, S Nanto, M Hori, T Ohara, Y Kim, Y Takano, K Sakamoto, K Kamado, S Kubori, H Kusuoka, and T Nishimura
Diabetes Care 1996 19: 887-891. [Abstract]  

Notes on the GENNID Study

RC Turner and JC Levy
Diabetes Care 1996 19: 892-895.  

Should we use intensive insulin therapy after oral agent failure in type II diabetes?

JA Colwell
Diabetes Care 1996 19: 896-898.  

Addition of hydrolyzed guar to enteral feeding products in type I diabetic patients

AL Peters and MB Davidson
Diabetes Care 1996 19: 899-900.  

Do GAD antibodies at IDDM onset predict the clinical course of diabetes in children?

O Kordonouri, T Danne, and B Weber
Diabetes Care 1996 19: 901-902.  

Physicians and rehabilitation for patients with vision loss

FA Weisse
Diabetes Care 1996 19: 902-903.  

Reproducibility of Michigan Neuropathy Screening Instrument (MNSI). A comparison with tests using the vibratory and thermal perception thresholds

G Bax, C Fagherazzi, F Piarulli, A Nicolucci, and D Fedele
Diabetes Care 1996 19: 904-905.  

Conference report: approaches to the treatment of type II diabetes and developments in glucose monitoring and insulin administration

ZT Bloomgarden
Diabetes Care 1996 19: 906-909.  

Letters:

Beta-sympathomimetic therapy of premature labor

D Lorber and E Krim
Diabetes Care 1996 19: 899.  

Lack of diabetes in rural Colombian Amerindians

I Briceno, LA Barriocanal, SS Papiha, LA Ashworth, A Gomez, JE Bernal, KG Alberti, and M Walker
Diabetes Care 1996 19: 900-901.  

Effect of small sample volume on five glucose monitoring systems

FR Velazquez and D Bartholomew
Diabetes Care 1996 19: 903-904.  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.